Difference between revisions of "Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2) (Q10992)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: named entity (P78): Cardiomyopathies (disease - MeSH descriptor) (Q10853), #quickstatements; #temporary_batch_1592939248955)
 
(8 intermediate revisions by the same user not shown)
Property / named entity
 +
Property / named entity: angiotensin I converting enzyme 2 (gene) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Arrhythmias, Cardiac (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Thomas syndrome (disease - MeSH supplementary concept) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Human (species) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: 2019 novel coronavirus (species) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Heart Failure (disease - MeSH descriptor) / rank
 +
Normal rank
Property / Collection or Dataset of Origin
 +
Property / Collection or Dataset of Origin: Pubtator Central BioC-JSON formatted article files / rank
 +
Normal rank

Latest revision as of 23:41, 20 October 2020

Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2
Language Label Description Also known as
English
Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2)
Publication: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty"published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34 DOI: 10.1007/s11886-020-01293-2

    Statements

    instance of
    Segment
    0 references
     

    Sitelinks

    Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q10992&oldid=229828"